The granule cells of the dentate gyrus (DG) are considered to be glutamatergic but they contain glutamic acid decarboxylase, -amino butyric acid (GABA), and the vesicular GABA transporter mRNA. Their expression is regulated in an activity dependent manner and coincides with the appearance of GABAergic transmission from the mossy fibers (MF) to pyramidal cells in area CA3. These data support the hypothesis that MF are able to release glutamate and GABA. Following the principle that a given neuron releases the same neurotransmitter(s) onto all its targets, we here demonstrate the emergence, after a generalized convulsive seizure, of MF GABAergic signaling sensitive to activation mGluR-III onto pyramidal cells and interneurons of CA3. Despite this, excitation overrides inhibition in interneurons, preventing disinhibition. Furthermore, upon blockade of GABA and glutamate ionotropic receptors, an M1-cholinergic depolarizing signal is also revealed in both targets, which postsynaptically modulates the glutamatergic and GABAergic fast neurotransmission. The emergence of these non-glutamatergic signals depends on protein synthesis. In contrast to cholinergic responses evoked by associational/commissural fibers activation, cholinergic transmission evoked by DG stimulation is only observed after seizures and is strongly depressed by the activation of mGluR-II, whereas both are depressed by M2-AChR activation. With immunohistological experiments, we show that this cholinergic pathway runs parallel to the MF. Thus, seizures compromise a delicate balance of excitation and inhibition, upon which a complex interaction of different neurotransmitters emerges to counteract excitation at pre-and post-synaptic sites.
INTRODUCTION
The normally glutamatergic granule cells of the dentate gyrus monosynaptically excite pyramidal cells and interneurons in hippocampal area CA3 through their mossy fibers (MF).
The interneurons are the main targets of the MF (Acsády et al., 1998) ; therefore, after being excited, they inhibit pyramidal cells and other interneurons (Miles et al., 1996; Urban and Barrionuevo, 1998) . Thus, excitatory and inhibitory synaptic responses in CA3 to MF stimulation disappear when glutamatergic transmission is blocked, indicating that GABAergic responses are disynaptically mediated (Dichter and Spencer, 1969; Yamamoto, 1972; Crawford and Connor, 1973; Buzsáki, 1984) .
However, we recently demonstrated that after seizures (Gutiérrez, 2000; Gutiérrez and Heinemann, 2001) or after synaptic or direct kindling-like stimulation of the DG in vitro without inducing epileptiform activity (Gutiérrez, 2002) , MF activation evokes monosynaptic GABAergic potentials in pyramidal cells. This and immunohistochemical (Sloviter et al., 1996; Schwarzer and Sperk, 1995; Ramírez and Gutiérrez, 2001 ) and neurochemical evidence (Taupin et al., 1994a,b; Gómez-Lira et al., 2002) suggest that granule cells can synthesize and release GABA in an activity-dependent manner. Furthermore, we also demonstrated that the granule cells and their MF contain and express the vesicular GABA transporter (VGAT) mRNA in an activity-dependent manner (Lamas et al., 2001 ).
It is a general principle that all the terminals of a given neuron release the same neurotransmitter(s). However, because the MF are functionally compartmentalized (Maccaferri et al., 1998; Tóth et al., 2000) , it is reasonable to consider the possibility that release of glutamate and GABA from MF could also be segregated according to the type of target onto which they impinge. Therefore, to support the hypothesis that MF release glutamate and GABA, it was important to test whether the simultaneous glutamatergic and JN-00985-2002.R2 4 GABAergic transmission is expressed onto both MF targets in CA3: the pyramidal cells and the interneurons.
Interestingly, in a previous study (Gutiérrez and Heinemann, 2001) we described that after the blockade of the aforementioned MF-evoked GABAergic response a putative cholinergic response could be uncovered. However, cholinergic transmission to area CA3 has been shown to come exclusively from the associational/commissural fibers (A/C) and its modulation in the MF projection is exerted through indirect synaptic interactions, whereby inhibitory interneurons are excited and presynaptically modulate MF glutamate release (Vogt and Regehr, 2001) . In view of this, we decided to characterize the seizureinduced DG-evoked cholinergic transmission onto CA3 and compare it to that evoked by the stimulation of the stratum radiatum, where the A/C pathway is known to pass (Vogt and Regehr, 2001 ). This would also clarify how these responses interact in CA3 neurons.
Here we demonstrate that after a generalized convulsive seizure, DG activation evokes monosynaptic GABAergic and M1-cholinergic responses both in pyramidal cells and interneurons of CA3, through the activation of different pathways, each with a distinctive pharmacological profile that permits their selective presynaptic modulation. Their emergence depends on protein synthesis.
METHODS

Electrophysiological recordings and analysis
For our electrophysiological experiments, we used control and pentylenetetrazol (PTZ)-injected Wistar rats (230-250 g). The i.p. injection of PTZ (Sigma; 70 mg/kg) invariably induced a generalized convulsive clonic-tonic seizure that lasted 80-120 sec, after which myoclonias and wet dog shakes were apparent. The rats were decapitated under deep JN-00985-2002.R2 5 ether anesthesia. All experimental procedures were approved by the Committee on Ethical Animal Research of our Institution and of the Ministry of Health. Brains were rapidly dissected and combined entorhinal cortex-hippocampus slices (400 µm) were cut with a vibro slicer (Campden Instruments, England) submerged in oxygenated artificial cerebrospinal fluid (ACSF) at 4°C. The PTZ-treated group was decapitated one hour after the injection. For some experiments, slices from control and PTZ-treated rats were incubated in artificial cerebrospinal fluid (ACSF) in the presence of cycloheximide (60 µM) or anisomycin (100 µM; Otani et al., 1992; Jones et al., 1992) for at least 2 h before they were transferred to the recording chamber. All slices, including those pre-incubated with the protein synthesis blockers, were transferred to a moisturized air-liquid interface recording chamber where they were constantly perfused with oxygenated normal ACSF at 35°C for one hour before the recordings started. The ACSF contained (in mM): NaCl, 124; KCl, 3; NaH 2 PO 4 , 1.25; MgSO 4 , 2; CaCl 2 , 2; NaHCO 3 , 26; glucose 10; pH 7.35. The drugs used were diluted at the desired concentration in the ACSF, namely: the NMDA type glutamate receptor antagonist, (DL)-2-amino-5-phosphonovaleric acid (APV; 30 µM; Tocris), and the non-NMDA type glutamate receptor antagonist 6-nitro-7-sulphamoylbenzo(f)quinolaxine-2,3-dione (NBQX; 10 µM; Tocris); the GABA A receptor antagonist bicuculline methiodide (20 µM; Sigma); the GABA B receptor antagonist CGP55845A (1 µM; a gift from Novartis); the M1-cholinergic antagonists: pirenzepine (10 µM; RBI), atropine (10 µM, Sigma), and muscarinic toxin (MT7; 100 nM; Peptide Institute Inc.); the M2-cholinergic agonist oxotremorine (1 µM; Sigma); the group II mGluR agonist (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV; 1 µM; Tocris); the group III mGluR agonist L(+)-2-amino-4-phosphonobutyric acid (L-AP4; 10 µM; Tocris); and the protein synthesis inhibitors, cycloheximide (60 µM; Sigma) and anisomycin (100 µM; JN-00985-2002.R2 6 Sigma).
An hour after incubation in normal ACSF, intracellular recordings were done with an AxoClamp 2B amplifier (Axon Instruments) and borosilicate microelectrodes (70-90 M ;
Brown-Flaming Puller) filled with 2M potassium acetate and 2% biocytin (Sigma).
Electrophysiologically identified pyramidal cells were recorded from regions CA3a and b, and interneurons were all recorded from the marginal zone between the stratum lucidum and stratum pyramidale of region CA3b (Fig. 1) . Anatomical identification of the recorded cells was later carried out by the intracellular injection of biocytin. The signals were acquired and analyzed off-line with the program pClamp8 (Axon Instruments). The duration of the action potential, and the duration and amplitude of the afterhyperpolarization were measured as previously described (Scharfman, 1995) . The onset latency of the synaptic responses was measured from the beginning of the stimulation artifact to the first inflection point of the first derivative of the synaptic potential with the cursor measure function of Clampfit. Membrane input resistance, and rise time and time to peak of the synaptic responses were measured with the built-in functions of Clampfit. The results are expressed as mean " s.e.m.
Electrical stimulation was provided with bipolar glass-insulated platinum wire (50 µm) electrodes over the molecular layer of the DG and over the stratum radiatum of the CA3 region (Vogt and Regehr, 2001; Fig. 1A) . Pulses of 0.1 ms were delivered at a current intensity that evoked 75% of the EPSP amplitude needed to reach threshold for evoking action potentials. In the CA3 region, a glass pipette (1-2 M ) filled with ACSF was positioned 200-300 µm apart from the recorded cell to stimulate local interneurons with monopolar pulses of 0.1 ms. JN-00985-2002.R2 7 Immunohistological experiments MF intracellular labeling. Slices to which a crystal of dextran, fluorescein (MW 3000; Molecular Probes) was inserted in the granular cell layer of the DG with a patch pipette were perfused with ACSF for 5 hours and immersed in phosphate buffer (0.1 M; pH 7.4) with paraformaldehyde (4%) for 12 hours and then transferred to a buffer with sucrose (30%) for 24 hours. They were frozen and cut at 14 µm in a cryostate (LEICA, CM 1850) and recovered in gelatin-coated slices. Some slices were counterstained with Evans blue (Sigma). These were covered with Vectashield (Vector) and observed and photographed under an epifluorescence microscope with appropriate filters for FITC and Texas Red (Nikon Optiphot-2).
For detection of ChAT immunoreactivity, 4 slices from 2 PTZ-treated-and from 2 control rats were processed after MF dextran, fluorescein staining. The slices were fixed in phosphate buffer (0.1 M; pH 7.4) with paraformaldehyde (2%) and picric acid (0.18%) for 12 hours and transferred to a buffer with sucrose (30%) for 24 hours. The slices were frozen, cut and mounted as described above. Sections were preincubated with BSA (5%) for 2 h and incubated with goat polyclonal anti-ChAT (human) antibody (1:200; Chemicon) in PBS, Triton X-100 (0.3%) and BSA (5%) overnight in a humid atmosphere at room temperature. For control purposes, some sections were simultaneously processed in the absence of the primary antibody. After rinsing, they were incubated with biotinilated anti- 
RESULTS
Typical responses of pyramidal cells to depolarizing pulses showed a burst of 2 or 3 action potentials followed by a hyperpolarization. On the other hand, interneurons recorded in the marginal zone between the stratum lucidum and stratum pyramidale of region CA3b were characterized by a sustained firing of action potentials during the depolarizing pulse, with little or no accommodation (Fig. 1A,B) . Cells that did not meet these criteria were not included in our study. The duration and shape of the action potential were distinctive for each cell type. The characteristics of the action potential, the resting membrane potential (rmp) and input resistance of both types of cells in control and PTZ-treated preparations are summarized in Table I .
Synaptic responses of pyramidal cells and interneurons to MF activation in control preparations.
DG stimulation evoked in pyramidal cells and interneurons EPSP/IPSP sequences, which were completely blocked by the perfusion of non-NMDA and NMDA receptors' antagonists (NBQX and APV; Fig. 1A,B) . The values of the amplitude, onset latency, time to peak and rise time of the monosynaptic control EPSP in pyramidal cells and interneurons are JN-00985-2002.R2 9 summarized in Table I. MF activation provokes GABAergic synaptic responses in pyramidal cells and interneurons after seizures.
Upon DG stimulation, the pyramidal cells of the PTZ group responded with EPSP/IPSP sequences ( Fig. 2A 1 ,C 1 , 3A 1 ). In interneurons, however, only an EPSP was evident ( Fig. 2A 2 , C 2 , 3A 2 ). The values of the amplitude, onset latency, time to peak and rise time of the monosynaptic EPSP in pyramidal cells and interneurons are summarized in Table I . As compared to the control preparations, the amplitude, rise time and time to peak of the EPSP evoked in both types of cells were statistically different in the PTZ group (Student ttest; p<0.01; the stimulation intensity was normalized as described in the Methods section). Fig. 3A 1,2 ). JN-00985-2002.R2 10 DG stimulation evokes cholinergic responses in CA3 after seizures In contrast to control slices, in PTZ-treated preparations the stimulation of the DG in the presence of glutamate receptors' antagonists and bicuculline provoked a slow depolarizing potential (EPSPm), both in pyramidal cells (Fig. 3A 1 ) and interneurons (Fig. 3A 2 ) . The mean amplitude, rise time, duration and onset latency for this EPSPm both in pyramidal cells and interneurons are summarized in Table I . Upon higher stimulation intensity, this EPSPm was enhanced but did not evoke action potentials in neither of the CA3 targets (not shown).
We then compared the EPSPm evoked by stimulation of the DG to that evoked by stimulation of the A/C fibers (Vogt and Regehr, 2001 ). The characteristics of the A/Cevoked EPSPm are depicted in Table I . Figure 3B antagonists block all synaptic responses to DG stimulation in control animals but A/C stimulation evoked an EPSPm that could be pharmacologically isolated by perfusion of glutamatergic and GABA A,B antagonists ( Fig. 3B 2 ) . On the contrary, in the PTZ-group, DG stimulation evoked an EPSPm in the presence of glutamatergic and GABAergic antagonists. The selective M1 cholinergic blockers: atropine (10 µM; n=40), pirenzepine (10 µM; n=50) and MT7 (100 nM; n=6), completely blocked the EPSPm evoked by both sites of stimulation, confirming unequivocally that they were mediated by M1 cholinergic receptors (Fig. 3C) . Current pulses applied during the EPSPm revealed an increment of the input resistance of the pyramidal cells by 39"7% (n=5; Fig. 3D ).
Alternatively, to determine if the blockade of cholinergic receptors prior to the perfusion of the GABA A antagonist could alter the MF-evoked IPSP, we perfused JN-00985-2002.R2 11 cholinergic antagonists in the presence of glutamate receptors' antagonists. In these conditions the MF IPSP evoked in pyramidal cells and interneurons had the characteristics depicted in Table I , that show that the amplitude of the MF IPSP increases due to the blockade of the antagonizing depolarizing action of the cholinergic signal (Fig. 4A,B ) and the reversal potential of the IPSP shifts to -72.4 ± 0.6 (n=9), coinciding with the reversal potential of the IPSP evoked by direct stimulation of interneurons (-72± 0.8 mV; n=10), which does not recruit cholinergic fibers.
The DG evoked synaptic signals have a distinctive presynaptic modulation.
Since activation of mGluR reduces neurotransmitter release from MF, we tested the effect of the mGluR-II agonist, DCG-IV, and of the mGluR-III agonist, L-AP4 on the MF-evoked responses. We tested the effect of both agonists in a group of cells and found that the inhibitory effect of DCG-IV on the MF IPSP was milder (26 %) than the effect of L-AP4, which depressed the MF IPSP by 84 % (n=11; Fig. 4 D,E), coinciding with previously reported data (Gutiérrez, 2000 (Gutiérrez, , 2002 Walker et al., 2001 ). This effect is selective for the MF-evoked IPSP, since the inhibitory potentials evoked by direct stimulation of intrinsic interneurons of area CA3 were not affected (n=6; Fig. 4D ). Moreover, we found that L-AP4 perfused during the maximal effect of DCG-IV further inhibited the MF IPSP (Fig. 4F) .
Thereafter, the effect of L-AP4 was tested in the GABAergic synaptic responses in the first and last cells recorded from each slice (we usually recorded 3-4 cells per slice). L-AP4 inhibited the MF-IPSP to the same extent in 44 out of 44 cells tested.
Since L-AP4 has the ability to depress the MF-evoked IPSP, therefore, in the presence of glutamate receptors' antagonists, it should depress the IPSP and would uncover the underlying EPSPm, provided that the latter is not sensitive to L-AP4. As shown JN-00985-2002.R2 12 in fig. 4C , L-AP4 strongly inhibits the IPSP without altering the EPSPm (n=4). On the other hand, perfusion of L-AP4 had no effect on the isolated mEPSP (not shown).
To study the presynaptic modulation of the different cholinergic responses of pyramidal cells evoked by DG and A/C stimulation, EPSPm were evoked successively in the same pyramidal cells by alternating the site of stimulation (as depicted in figure 3B ) in the presence of glutamatergic and GABAergic antagonists (n=93). Also, the GABA Bdependent IPSP was blocked with CGP55845A (n=12). Under these conditions, we found that DCG-IV virtually blocked the DG-but not the A/C evoked cholinergic responses, which remained unaltered (n=5; Fig. 5A,B) . The responses to a paired pulse potentiation protocol showed that the effects are consistent with a presynaptic action of DCG-IV (Fig. 5B) . Thus, the activation of mGluR-II, but not of mGluR-III, inhibits the DG-but not the A/C -driven EPSPm. Due to this, one can think that MF could also be mediating the cholinergic potential. However, since unlike extrinsic cholinergic fibers MF do not express M2 receptors, we tested the effect of the M2 agonist, oxotremorine, on the EPSPm evoked by stimulation of both pathways. Oxotremorine completely and reversibly depressed both EPSPm (n=5; Fig. 5C,D) , showing that the cholinergic transmission from the DG to CA3 is not of MF origin and, contrary to the A/C cholinergic responses, is modulated by mGluR-II.
For comparison purposes, we assessed the effect of oxotremorine on the fast glutamatergic DG-evoked EPSP of control preparations and confirmed its lack of effect (n=5; Fig 5D) .
The emergence of non-glutamatergic signaling from the DG to CA3 after seizures depends on protein synthesis
Since the induction of the MF IPSP in vitro depends on protein synthesis (Gutiérrez, 2002) , JN-00985-2002.R2 13 we tested the effect of cycloheximide and anisomycin, protein synthesis blockers, on the seizure-induced non-glutamatergic signaling from the DG to CA3. After pre-incubation of the slices from seizing-rats in the protein synthesis blockers (see methods), synaptic potentials were evoked by DG and direct interneuron stimulation in pyramidal cells (9 for each inhibitor) and interneurons (n=3; anisomycin). The perfusion of glutamate receptors'
antagonists blocked all synaptic responses evoked by DG but not by direct stimulation of local interneurons in all the pyramidal cells and interneurons tested (Fig. 6) . For comparison purposes, we carried out the same experiments in slices from control nontreated rats and from slices prepared from PTZ-treated rats 3 hours after the onset of the seizure. In the former, EPSP/IPSP sequences could normally be evoked by DG stimulation. The perfusion of glutamate receptors' antagonists blocked all synaptic potentials evoked by DG stimulation, whereas an IPSP was evoked by direct interneuron stimulation, as previously shown in control non-treated slices (n=5 for each inhibitor). On the other hand, in slices prepared 3 hours after the seizure and then incubated in the blockers, non-glutamatergic transmission from DG to CA3 could still be evoked (not shown).
Cholin-acetyl-transferase (ChAT)-positive fibers pass through the DG and along MF in CA3
After anatomically identifying the MF with topical application of dextran, fluorescein into the DG (Fig. 7A-B) , we carried out immunofluorescence staining to ChAT (Fig. 7C-E) . Control experiments, in which slices were processed in the absence of primary antibody, did not present immunoreactivity (not shown). We were able to discard the colocalization of ChAT and dextran, fluorescein in the granule cells or their MF both in control and PTZ-treated preparations. The perisomatic region of pyramidal cells and granule cells was densely JN-00985-2002.R2 14 immunoreactive to ChAT, where ChAT positive terminals were evident (Fig. 7C 1,2 ) . Also, fine fibers could be localized in stratum lucidum (Fig. 7C 2 ) . In addition, we found few cholinergic interneurons in the molecular layer of the DG (Fig. 7D 1 ) , whose orientation and terminals were restricted to the DG. Fibers positive to ChAT could be traced passing through the molecular (Fig. 7D 1 ) and granular cell layers (Fig.76D 2 ) . We found no apparent differences in ChAT staining between the control (Fig. 7C 1 ,D 1 ) and PTZ (Fig. 7C 2 ,D 2 ) groups.
DISCUSSION
Our results show that seizures induce simultaneous glutamatergic and GABAergic transmission from the MF to both their targets in CA3: the pyramidal cells and interneurons.
Together with these signals, an M1-AchR-mediated cholinergic response develops that affects both targets, where the synaptic signals interact. The emergence of these DGevoked GABAergic and cholinergic signals requires protein synthesis and each is subjected to selective presynaptic modulation. This, and our immunohistological and confocal microscopy experiments demonstrate that the cholinergic signal has an origin different from the mossy fibers. Figure 8 summarizes our conclusions.
Seizures induce simultaneous glutamatergic and GABAergic transmission from MF to its targets in area CA3.
Supporting the hypothesis that MF are able to release GABA, we show that the different targets of MF in area CA3 respond with simultaneous glutamatergic and GABAergic potentials. In control preparations, glutamate receptors' antagonists block all synaptic responses to DG stimulation both in pyramidal cells and interneurons, indicating JN-00985-2002.R2 15 that GABAergic potentials are disynaptically mediated. However, slices of the PTZ-treated group presented MF-evoked GABAergic responses in a condition in which all excitatory components are blocked, discarding polysynaptic contamination (Sik et al., 1994; Weisskopf and Nicoll, 1995) . However, there is evidence of the presence of GABAergic inputs to CA3, other than intrinsic interneurons, and of interneurons within area CA3c that can reach the hilar region (Sik et al., 1997) . Although activation of these inputs cannot be entirely ruled out, the possibility that the GABAergic responses seen in our experiments are that MF monosynaptic GABAergic signals can be normally detected in juvenile rats.
Therefore, the release of GABA from MF in the rat has possibly been previously observed (Ben-Ari et al., 1989), but not identified as such. In the light of our previous (Gutiérrez, JN-00985-2002.R2 17 2002) and present results, MF-GABAergic transmission can be recognized by its sensitivity to mGluR-III activation. It has been considered that MF glutamatergic neurotransmission in the rat is sensitive to the mGluR-II agonist, DCG-IV, but not to the mGluR-III agonist, L-AP4. The contrary is true for MF neurotransmission in the guinea pig (Lanthorn et al., 1984; Bradley et al., 1996; Shigemoto et al., 1997; but see Ohishi et al., 1993 but see Ohishi et al., , 1995 . That MF GABAergic signaling is strongly inhibited by the activation of the mGluR-III permits to suggest a link of mGluR-III to the GABA releasing machinery, and of mGluR-II to the glutamate releasing machinery, which has been shown to produce a downregulation of the exocytotic machinery (Kamiya and Ozawa, 1999). Therefore, not only an inhibition of Ca . Electron microscopy has revealed immunolabeling for the mGluR-III predominantly in presynaptic active zones of asymmetrical and symmetrical synapses, whereas mGluR-II immunolabeling was found in preterminal rather than terminal portions of axons (Shigemoto et al., 1996 (Shigemoto et al., ,1997 . Our data suggest a presynaptic segregation of mGluR receptors according to the class of neurotransmitter to be released. Postsynaptically, GABA A receptors cluster apposed to glutamatergic terminals in cultured pyramidal hippocampal cells suggesting that there is an element common to GABA and glutamate synapses (Rao et al., 2000) .
Seizures induce mGluR-sensitive cholinergic transmission from the DG to pyramidal cells and interneurons in area CA3. JN-00985-2002.R2 18 Cholinergic responses of pyramidal cells and interneurons of the hippocampus usually appear upon high frequency or high intensity stimulation of their cholinergic afferents (Cole and Nicoll, 1984; Brunner and Misgeld, 1994; Müller and Misgeld, 1986; Morton and Davies, 1997; Morton et al., 2001) , whereas single-pulse stimulation over the DG in the presence of glutamate receptors' antagonists does not elicit synaptic responses in control preparations. However, after seizures, single-pulse stimulation over DG evokes M1-AChR dependent responses suggesting that these fibers are probably silent in normal conditions, and they become transiently active after seizures (Gutiérrez and Heinemann, 2001) . We now establish that this is a process dependent on protein synthesis.
It has been described that the cholinergic input from the septum exerts its modulation in the MF pathway through the activation of interneurons, which in turn affect pyramidal cells (Williams and Johnston, 1990; Martin and Alger, 1999; Vogt and Regehr, 2001 ). Our data show that M1-cholinergic signaling of DG origin directly activates both pyramidal cells and interneurons within CA3. This, contrary to the A/C evoked-cholinergic responses, is sensitive to activation of mGluR-II, whereas M2 -AChR activation depresses ACh release from both pathways. It has been described that activation of mGluR-II depresses MF but not A/C synapses (Manzoni et al., 1995) and muscarine directly inhibits the A/C synapse without directly affecting the MF synapse (Vogt and Regehr, 2001), which does not have M2 receptors (Hájos et al., 1998) , as we also confirm.
The cholinergic activation of different subsets of neurons and/or interneurons and, as we show, the activation of different cholinergic pathways with differential presynaptic modulation, regulate the overall synaptic integration in the hippocampus (Hasselmo and Fehlau, 2001) . Thus, in PTZ-treated preparations the DG-cholinergic signal postsynaptically modulates the convergent glutamatergic and GABAergic JN-00985-2002.R2 19 neurotransmission. In this way, this adds to other modulatory mechanisms in a pathway where spill over is a means by which collateral multi-target modulation is exerted together with pre-and postsynaptic interactions in a parallel fashion (Min et al., 1998; Hájos et al., 1998; Rusakov et al., 1999; Semyanov and Kullmann, 2000; Vogt and Regehr, 2001 ).
Anatomical findings
Our immunohistological data discards the presence of ChAT in the MF and disclose a pathway that probably runs in parallel to this projection. As previously shown (Frotscher and Léránth, 1985) we found ChAT-positive fibers to form a network around granule cells in the DG and pyramidal cells and interneurons in CA3. The terminals observed in the CA3 region are likely to be collaterals of those innervating the DG. In accordance with previous reports (Blaker et al. 1988; Frotscher et al., 2000) , we observe the presence of few cholinergic interneurons, whose arborizations terminate locally within the stratum moleculare of the DG. Additionally, Frotscher et al. (2000) showed that neither GAD 65 nor GAD 67 mRNA colocalizes with ChAT in cholinergic interneurons.
Functional implications
Our present data showing that MF glutamatergic and GABAergic neurotransmission can be observed both in pyramidal cells and interneurons, and that MF GABAergic signaling has a distinctive presynaptic modulation suggest that distinct MF fiber collaterals are involved in MF GABAergic neurotransmission (Gutiérrez, 2002) . Its emergence has net inhibitory effects on pyramidal cells since the activation of MF at high frequencies provokes the more pronounced IPSPs in pyramidal cells of PTZ-treated rats to summate, hyperpolarizing the cells (Gutiérrez and Heinemann, 2001) . Although here we prove that MF GABAergic JN-00985-2002.R2 20 transmission is also expressed onto interneurons, which are the main targets of the MF (Acsády et al., 1998), we show that MF glutamatergic excitation surpasses the inhibitory transmission. Thus, the interneurons are more readily excited than pyramidal cells, which continue to receive a strong inhibitory control from the interneurons within CA3, besides the MF GABAergic signal.
Beyond the attractive hypothesis of glutamate/GABA corelease from the MF, other important functional consequences arise. Our model (Fig. 8) proposes that selective activation of mGluR-II would inhibit excitatory transmission (glutamatergic from the MF, and cholinergic from the associated parallel fibers) but not MF inhibitory transmission, which in turn, can still exert presynaptic GABA B -R activation and postsynaptically act on pyramidal cells and interneurons. Contrariwise, activation of mGluR-III would selectively inhibit inhibitory transmission without consequences in excitatory transmission, which could still further activate presynaptic mGluR. Finally, short-and long-term changes in the cholinergic system due to epileptic and stress-related phenomena are known to exist (Lupica and Berman, 1988; Mingo et al., 1997 Mingo et al., , 1998 Serra et al., 1997; Ferencz et al., 2001; Friedman et al., 1996; Kaufer et al., 1998) , whether these are related phenomena needs to be disclosed. 
